Medicilon: Innovating Globally at CMC-China Expo 2025
CMC-China Expo 2025 August 1, 2025–The CMC-China Expo 2025, themed “Breakthrough, Symbiosis, and Globalization,” opened today at the Suzhou International Expo Centre. The conference gathers biopharmaceutical experts and executives to foster collaboration on innovative technologies and explore future industry development, addressing key topics to drive high-quality growth in the biopharmaceutical sector. Top 20 Preclinical CROs […]
Novamab Announces NMPA CDE Approval of IND for LQ036, the World’s First Inhaled Nanobody for Moderate-to-Severe Asthma
Novamab has announced that the CDE of the NMPA has approved its IND application for LQ036, the world’s first inhaled nanobody for moderate to severe asthma. LQ036 is a recombinant anti-IL-4Rα single-domain antibody nebulizing solution produced in Pichia pastoris. Medicilon leveraged its dedicated Inhalation Formulation R&D Platform to deliver high quality services for the inhalation […]
